Cargando…

Automated high-throughput image processing as part of the screening platform for personalized oncology

Cancer is a devastating disease and the second leading cause of death worldwide. However, the development of resistance to current therapies is making cancer treatment more difficult. Combining the multi-omics data of individual tumors with information on their in-vitro Drug Sensitivity and Resistan...

Descripción completa

Detalles Bibliográficos
Autores principales: Schilling, Marcel P., El Khaled El Faraj, Razan, Urrutia Gómez, Joaquín Eduardo, Sonnentag, Steffen J., Wang, Fei, Nestler, Britta, Orian-Rousseau, Véronique, Popova, Anna A., Levkin, Pavel A., Reischl, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060403/
https://www.ncbi.nlm.nih.gov/pubmed/36991084
http://dx.doi.org/10.1038/s41598-023-32144-z
_version_ 1785017089436680192
author Schilling, Marcel P.
El Khaled El Faraj, Razan
Urrutia Gómez, Joaquín Eduardo
Sonnentag, Steffen J.
Wang, Fei
Nestler, Britta
Orian-Rousseau, Véronique
Popova, Anna A.
Levkin, Pavel A.
Reischl, Markus
author_facet Schilling, Marcel P.
El Khaled El Faraj, Razan
Urrutia Gómez, Joaquín Eduardo
Sonnentag, Steffen J.
Wang, Fei
Nestler, Britta
Orian-Rousseau, Véronique
Popova, Anna A.
Levkin, Pavel A.
Reischl, Markus
author_sort Schilling, Marcel P.
collection PubMed
description Cancer is a devastating disease and the second leading cause of death worldwide. However, the development of resistance to current therapies is making cancer treatment more difficult. Combining the multi-omics data of individual tumors with information on their in-vitro Drug Sensitivity and Resistance Test (DSRT) can help to determine the appropriate therapy for each patient. Miniaturized high-throughput technologies, such as the droplet microarray, enable personalized oncology. We are developing a platform that incorporates DSRT profiling workflows from minute amounts of cellular material and reagents. Experimental results often rely on image-based readout techniques, where images are often constructed in grid-like structures with heterogeneous image processing targets. However, manual image analysis is time-consuming, not reproducible, and impossible for high-throughput experiments due to the amount of data generated. Therefore, automated image processing solutions are an essential component of a screening platform for personalized oncology. We present our comprehensive concept that considers assisted image annotation, algorithms for image processing of grid-like high-throughput experiments, and enhanced learning processes. In addition, the concept includes the deployment of processing pipelines. Details of the computation and implementation are presented. In particular, we outline solutions for linking automated image processing for personalized oncology with high-performance computing. Finally, we demonstrate the advantages of our proposal, using image data from heterogeneous practical experiments and challenges.
format Online
Article
Text
id pubmed-10060403
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-100604032023-03-31 Automated high-throughput image processing as part of the screening platform for personalized oncology Schilling, Marcel P. El Khaled El Faraj, Razan Urrutia Gómez, Joaquín Eduardo Sonnentag, Steffen J. Wang, Fei Nestler, Britta Orian-Rousseau, Véronique Popova, Anna A. Levkin, Pavel A. Reischl, Markus Sci Rep Article Cancer is a devastating disease and the second leading cause of death worldwide. However, the development of resistance to current therapies is making cancer treatment more difficult. Combining the multi-omics data of individual tumors with information on their in-vitro Drug Sensitivity and Resistance Test (DSRT) can help to determine the appropriate therapy for each patient. Miniaturized high-throughput technologies, such as the droplet microarray, enable personalized oncology. We are developing a platform that incorporates DSRT profiling workflows from minute amounts of cellular material and reagents. Experimental results often rely on image-based readout techniques, where images are often constructed in grid-like structures with heterogeneous image processing targets. However, manual image analysis is time-consuming, not reproducible, and impossible for high-throughput experiments due to the amount of data generated. Therefore, automated image processing solutions are an essential component of a screening platform for personalized oncology. We present our comprehensive concept that considers assisted image annotation, algorithms for image processing of grid-like high-throughput experiments, and enhanced learning processes. In addition, the concept includes the deployment of processing pipelines. Details of the computation and implementation are presented. In particular, we outline solutions for linking automated image processing for personalized oncology with high-performance computing. Finally, we demonstrate the advantages of our proposal, using image data from heterogeneous practical experiments and challenges. Nature Publishing Group UK 2023-03-29 /pmc/articles/PMC10060403/ /pubmed/36991084 http://dx.doi.org/10.1038/s41598-023-32144-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Schilling, Marcel P.
El Khaled El Faraj, Razan
Urrutia Gómez, Joaquín Eduardo
Sonnentag, Steffen J.
Wang, Fei
Nestler, Britta
Orian-Rousseau, Véronique
Popova, Anna A.
Levkin, Pavel A.
Reischl, Markus
Automated high-throughput image processing as part of the screening platform for personalized oncology
title Automated high-throughput image processing as part of the screening platform for personalized oncology
title_full Automated high-throughput image processing as part of the screening platform for personalized oncology
title_fullStr Automated high-throughput image processing as part of the screening platform for personalized oncology
title_full_unstemmed Automated high-throughput image processing as part of the screening platform for personalized oncology
title_short Automated high-throughput image processing as part of the screening platform for personalized oncology
title_sort automated high-throughput image processing as part of the screening platform for personalized oncology
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060403/
https://www.ncbi.nlm.nih.gov/pubmed/36991084
http://dx.doi.org/10.1038/s41598-023-32144-z
work_keys_str_mv AT schillingmarcelp automatedhighthroughputimageprocessingaspartofthescreeningplatformforpersonalizedoncology
AT elkhaledelfarajrazan automatedhighthroughputimageprocessingaspartofthescreeningplatformforpersonalizedoncology
AT urrutiagomezjoaquineduardo automatedhighthroughputimageprocessingaspartofthescreeningplatformforpersonalizedoncology
AT sonnentagsteffenj automatedhighthroughputimageprocessingaspartofthescreeningplatformforpersonalizedoncology
AT wangfei automatedhighthroughputimageprocessingaspartofthescreeningplatformforpersonalizedoncology
AT nestlerbritta automatedhighthroughputimageprocessingaspartofthescreeningplatformforpersonalizedoncology
AT orianrousseauveronique automatedhighthroughputimageprocessingaspartofthescreeningplatformforpersonalizedoncology
AT popovaannaa automatedhighthroughputimageprocessingaspartofthescreeningplatformforpersonalizedoncology
AT levkinpavela automatedhighthroughputimageprocessingaspartofthescreeningplatformforpersonalizedoncology
AT reischlmarkus automatedhighthroughputimageprocessingaspartofthescreeningplatformforpersonalizedoncology